Conquering Alzheimer’s: a look at the therapies of the future (Links to an external site) April 7, 2023
Focused ultrasound technique leads to release of neurodegenerative disorders biomarkers (Links to an external site) February 3, 2023February 3, 2023
FDA APPROVES LEQEMBI™ (LECANEMAB-IRMB) UNDER THE ACCELERATED APPROVAL PATHWAY FOR THE TREATMENT OF ALZHEIMER’S DISEASE (Links to an external site) January 7, 2023
[Ad hoc announcement pursuant to Art. 53 LR] Roche provides update on Phase III GRADUATE programme evaluating gantenerumab in early Alzheimer’s disease (Links to an external site) November 15, 2022
LECANEMAB CONFIRMATORY PHASE 3 CLARITY AD STUDY MET PRIMARY ENDPOINT, SHOWING HIGHLY STATISTICALLY SIGNIFICANT REDUCTION OF CLINICAL DECLINE IN LARGE GLOBAL CLINICAL STUDY OF 1,795 PARTICIPANTS WITH EARLY ALZHEIMER’S DISEASE (Links to an external site) September 28, 2022
Roche provides update on Alzheimer’s Prevention Initiative study evaluating crenezumab in autosomal dominant Alzheimer’s disease (Links to an external site) June 16, 2022
Blood test for Alzheimer’s highly accurate in large, international study (Links to an external site) February 23, 2022
Dementia First blood test to help diagnose Alzheimer’s goes on sale (Links to an external site) December 7, 2020March 23, 2021
Why Didn’t She Get Alzheimer’s? The Answer Could Hold a Key to Fighting the Disease (Links to an external site) November 4, 2019November 21, 2019